Praluent

The Daily Biotech Pulse: Sanofi, Regeneron Finalize Praluent Restructuring, Natus Pre-Announces Q1 Shortfall, Alcon To Delay Dividend Initiation

Regeneron Shares Swing On Sanofi's Hint At Sale Of Ownership Stake, Amendments To Drug Collaborations

Attention Biotech Investors: Mark Your Calendar For These April PDUFA Dates

Regeneron Shares Swing On Sanofi's Hint At Sale Of Ownership Stake, Amendments To Drug Collaborations

Attention Biotech Investors: Mark Your Calendar For These April PDUFA Dates

Attention Biotech Investors: Mark Your Calendar For These August PDUFA Dates

Strong Trial Results, Effective Distribution Could Put Regeneron's Praluent 'Back In The Competition'

Attention Biotech Investors: Mark Your Calendar For These August PDUFA Dates

Strong Trial Results, Effective Distribution Could Put Regeneron's Praluent 'Back In The Competition'

Amgen 'Disappointed' In Court Decision To Reverse Praluent Sales Ban

Sanofi May Now Have Moved Past Its Most Challenging Period, Analyst Initiates At Buy